An observational study in Hemoptysis, Perioperative Complication and Anaphylaxis, sponsored by University Hospital, Strasbourg, France. Status unknown. Open to participants aged 2 Years and older. Per ClinicalTrials.gov, last updated 2021-04-01.
Sponsored by University Hospital, Strasbourg, France · Observational
Anaphylaxis is a severe and life-threatening complication during the perioperative period. Perioperative anaphylaxis is still associated with a significant mortality despite quick and efficient management using epinephrine, the mainstay of acute treatment. Experimental data and few case reports are suggesting that hemostasis, and more precisely platelets, could play a role in anaphylaxis. Our main hypothesis is that activation of the hemostatic system contributes to the severity of the reaction
37 studies on the registry are indexed under Hemoptysis; 6 are open to participants now.
This study's planned enrollment of 30 is below the median of 176 across 15 observational studies indexed under Hemoptysis.
Browse Hemoptysis studies →University Hospital, Strasbourg, France is the lead sponsor of 999 studies on the registry; 358 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study will focus on any adult patient with a suspected diagnosis of perioperative anaphylactic shock
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Platelet activation
Measurement of: Plasmatic serotonin level, Plasmatic PF-4 level, P-selectin expression (MFI, %), Platelet count
Time frame: As soon as possible after onset of anaphylaxis
Platelet activation
Measurement of: Plasmatic serotonin level, Plasmatic PF-4 level, P-selectin expression (MFI, %), Platelet count
Time frame: 1-2 hours after the onset of anaphylaxis
Platelet activation
Measurement of: Plasmatic serotonin level, Plasmatic PF-4 level, P-selectin expression (MFI, %), Platelet count
Time frame: 24 hours after the onset of anaphylaxis
Platelet activation
Measurement of: Plasmatic serotonin level, Plasmatic PF-4 level, P-selectin expression (MFI, %), Platelet count
Time frame: During the allergic workup (4-6 weeks after)
No study locations are listed for this record.
This study is status unknown, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Strasbourg, France →